HHS anti-kickback and Stark proposed rules: Impact on value-based care and longstanding regulatory hurdles

CMS and OIG proposed wide-ranging protections for value-based arrangements and provided guidance on a number of regulatory challenges under the AKS and Stark Law. On November 14, join us...

Proposed AKS rewrite on drug rebates: The impact and challenges ahead

The Trump Administration recently proposed what is arguably the most sweeping change to the regulatory safe harbors for the federal health care anti-kickback statute in decades. The...

The U.S. legal considerations and changes in telehealth

On 3 October 2018 we hosted a complimentary webinar discussing the recent and proposed changes in the coverage of telehealth services, potential future developments, and some of the key...

The Evolving Role of Compliance in Healthcare Fraud Investigations

The Department of Justice Criminal Fraud Section recently released the "Evaluation of Corporate Compliance Programs" guidance document. This publication emphasizes that compliance and...

The Consideration of Compliance Programs in Criminal Investigations

Partners Thomas Beimers and Gejaa Gobena presented "The Consideration of Compliance Programs in Criminal Investigations," a webinar sponsored by the Health Care Compliance Association.

What to Expect in Post-Escobar FCA Litigation

Partner Thomas Beimers presented "What to Expect in Post-Escobar FCA Litigation" as part of a Minnesota CLE seminar called "2016 Advanced Healthcare Fraud and Abuse Update."

Recent CIAs & Compliance Effectiveness

On October 25, 2016, partner Thomas Beimers presented a breakout session, "Recent CIAs & Compliance Effectiveness," at the Health Care Compliance Association Enforcement Institute in...

Hubs and Specialty Pharmacy Arrangements: Structuring Service Agreements

On October 20, 2016, partner Thomas Beimers presented "Hubs and Specialty Pharmacy Arrangements: Structuring Service Agreements" at the 17th Annual Pharmaceutical and Medical Device...

Loading data